ConcertAI’s TeraRecon Launches TeraRecon Neuro Clinical Workflow Solution

October 5, 2022—ConcertAI’s TeraRecon, an artificial intelligence (AI) and advanced visualization platform for medical imaging, announced the release of its AI-driven clinical workflow solution, TeraRecon Neuro.

According to the company, TeraRecon Neuro is intended for disease screening and care activation in neurovascular emergencies. It is designed to integrate across the entire health care organization and address most challenges that clinicians face when making decisions about care in a life-threatening situation, such as a stroke. It is viewable on both a diagnostic desktop viewer and a mobile application.

TeraRecon Neuro was created to increase a facility’s emergency readiness for hemorrhagic and ischemic neurologic cases using various types of imaging modalities.

The workflow solution offers automatic screening of suspected intracerebral hemorrhages and large vessel occlusions to improve access and time-to-decision of viable treatment options for patients, thus potentially improving functional patient outcomes.

In addition, automated CT perfusion maps help clinicians assess brain function using six customizable maps, all of which can be integrated into TeraRecon’s Intuition platform for continuity across the care continuum.

TeraRecon Neuro’s analytics and capabilities enable the physician to interact with the AI algorithm within the workflow to improve the AI outputs, stated the company.